P253 ARV-471, a PROTAC® estrogen receptor (ER) degrader in advanced ER+/human epidermal growth factor receptor 2 (HER2)- breast cancer: phase 2 expansion (VERITAC) of a phase 1/2 study. (April 2023)

Record Type:: Journal Article
Title:: P253 ARV-471, a PROTAC® estrogen receptor (ER) degrader in advanced ER+/human epidermal growth factor receptor 2 (HER2)- breast cancer: phase 2 expansion (VERITAC) of a phase 1/2 study. (April 2023)
Main Title:: P253 ARV-471, a PROTAC® estrogen receptor (ER) degrader in advanced ER+/human epidermal growth factor receptor 2 (HER2)- breast cancer: phase 2 expansion (VERITAC) of a phase 1/2 study
Authors:: Hurvitz, S.A
Schott, A.F
Ma, C.
Hamilton, E.P
Nanda, R.
Zahrah, G.
Hunter, N.
Tan, A.R
Telli, M.L
Mesias, J.A.
Jeselsohn, R.
Munster, P.
Lu, H.
Gedrich, R.
Mather, C.
Parameswaran, J.
Han, H.S
Wirth, S.
Abstract:
Is Part Of:: Breast. Volume 68(2023)Supplement
Journal:: Breast
Issue:: Volume 68(2023)Supplement
Issue Display:: Volume 68, Issue 2023 (2023)
Year:: 2023
Volume:: 68
Issue:: 2023
Issue Sort Value:: 2023-0068-2023-0000
Page Start:: S116
Page End:
Publication Date:: 2023-04
Subjects:: Breast -- Diseases -- Periodicals
Breast -- Tumors -- Periodicals
Breast -- Periodicals
Electronic journals
Periodicals
616
Journal URLs:: http://www.sciencedirect.com/science/journal/09609776 ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0960-9776;screen=info;ECOIP ↗
http://www.harcourt-international.com/journals/brst/ ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09609776 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09609776 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0960-9776(23)00371-5 ↗
Languages:: English
ISSNs:: 0960-9776
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 2277.492700
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 26156.xml